Zhou YQ - Search Results

1

The Role of CXCR3 in Neurological Diseases.

Zhou YQ, Liu DQ, Chen SP, Sun J, Zhou XR, Xing C, Ye DW, Tian YK. Zhou YQ, et al. Among authors: zhou xr. Curr Neuropharmacol. 2019;17(2):142-150. doi: 10.2174/1570159X15666171109161140. Curr Neuropharmacol. 2019. PMID: 29119926 Free PMC article. Review.

2

Chemokines and Their Receptors: Potential Therapeutic Targets for Bone Cancer Pain.

Zhou YQ, Gao HY, Guan XH, Yuan X, Fang GG, Chen Y, Ye DW. Zhou YQ, et al. Curr Pharm Des. 2015;21(34):5029-33. doi: 10.2174/1381612821666150831141931. Curr Pharm Des. 2015. PMID: 26320755 Review.

3

Minocycline attenuates bone cancer pain in rats by inhibiting NF-κB in spinal astrocytes.

Song ZP, Xiong BR, Guan XH, Cao F, Manyande A, Zhou YQ, Zheng H, Tian YK. Song ZP, et al. Among authors: zhou yq. Acta Pharmacol Sin. 2016 Jun;37(6):753-62. doi: 10.1038/aps.2016.1. Epub 2016 May 9. Acta Pharmacol Sin. 2016. PMID: 27157092 Free PMC article.

4

Isoflurane enhances the malignant potential of glioblastoma stem cells by promoting their viability, mobility in vitro and migratory capacity in vivo.

Zhu M, Li M, Zhou Y, Dangelmajer S, Kahlert UD, Xie R, Xi Q, Shahveranov A, Ye D, Lei T. Zhu M, et al. Br J Anaesth. 2016 Jun;116(6):870-7. doi: 10.1093/bja/aew124. Br J Anaesth. 2016. PMID: 27199319 Free article.

5

Association of miR-608 rs4919510 polymorphism and cancer risk: a meta-analysis based on 13,664 subjects.

Liu H, Zhou Y, Liu Q, Xiao G, Wang B, Li W, Ye D, Yu S. Liu H, et al. Oncotarget. 2017 Jun 6;8(23):37023-37031. doi: 10.18632/oncotarget.9509. Oncotarget. 2017. PMID: 27223084 Free PMC article.

6

Interleukin-6: an emerging regulator of pathological pain.

Zhou YQ, Liu Z, Liu ZH, Chen SP, Li M, Shahveranov A, Ye DW, Tian YK. Zhou YQ, et al. J Neuroinflammation. 2016 Jun 7;13(1):141. doi: 10.1186/s12974-016-0607-6. J Neuroinflammation. 2016. PMID: 27267059 Free PMC article. Review.

7

Targeting glia for bone cancer pain.

Zhou YQ, Liu Z, Liu HQ, Liu DQ, Chen SP, Ye DW, Tian YK. Zhou YQ, et al. Expert Opin Ther Targets. 2016 Nov;20(11):1365-1374. doi: 10.1080/14728222.2016.1214716. Epub 2016 Jul 27. Expert Opin Ther Targets. 2016. PMID: 27428617 Review.

8

MHC-I promotes apoptosis of GABAergic interneurons in the spinal dorsal horn and contributes to cancer induced bone pain.

Fu Q, Shi D, Zhou Y, Zheng H, Xiang H, Tian X, Gao F, Manyande A, Cao F, Tian Y, Ye D. Fu Q, et al. Exp Neurol. 2016 Dec;286:12-20. doi: 10.1016/j.expneurol.2016.09.002. Epub 2016 Sep 13. Exp Neurol. 2016. PMID: 27619625

9

STAT1 as a downstream mediator of ERK signaling contributes to bone cancer pain by regulating MHC II expression in spinal microglia.

Song Z, Xiong B, Zheng H, Manyande A, Guan X, Cao F, Ren L, Zhou Y, Ye D, Tian Y. Song Z, et al. Brain Behav Immun. 2017 Feb;60:161-173. doi: 10.1016/j.bbi.2016.10.009. Epub 2016 Oct 11. Brain Behav Immun. 2017. PMID: 27742579

10

PI3K/Akt Pathway: A Potential Therapeutic Target for Chronic Pain.

Chen SP, Zhou YQ, Liu DQ, Zhang W, Manyande A, Guan XH, Tian YK, Ye DW, Omar DM. Chen SP, et al. Among authors: zhou yq. Curr Pharm Des. 2017;23(12):1860-1868. doi: 10.2174/1381612823666170210150147. Curr Pharm Des. 2017. PMID: 28190392 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

725 results

Search Page

Filters